Winston Patrick Kuo Email & Phone Number

California, United States

Hayward, Ca, Us

Hayward, Ca, Us

Vision: Bring the best hospital to every community and bring the best doctor to every homeMission: Empower the global healthcare ecosystem through innovationPredicine a global molecular insights company that is committed to advancing precision medicine in oncology and infectious diseases. Predicine has developed a proprietary cell-free DNA- and cell-free RNA-based liquid biopsy technology enabling minimally invasive molecular diagnosis for treatment selection, therapy monitoring, and minimal residual disease and early cancer detection. The company has launched a portfolio of blood-, urine- and tissue-based molecular diagnostic assays for oncology and infectious diseases. Through its business operations in US-EU-APAC-China, Predicine partners with leading biopharma companies, institutions, and governments to support personalized healthcare on a global scale. Predicine operates in CLIA and CAP certified facilities in US (Silicon Valley, Chicago, Houston) and China (Shanghai) with business offices in Singapore, Berlin, Boston, Tustin, Beijing, Suzhou and Harbin. Currently, Predicine partners with leading biopharma companies and hospitals to support patient testing, clinical trials and CDx development in US, China, EU, Japan, Australia, among others. http://www.predicine.comPredicine, Care for Life!

Hayward, Ca, Us

Predicine, a CLIA/CAP certified lab expanded its infrastructure and services to provide COVID-19 testing solutions to the Bay Area. Testing options included RT-PCR, NGS, antigen and IgM/IgG antibody tests. Flexible collections - clinic visits, on-site and At-Home solutions. Currently providing tests for travelers, schools, nursing homes, urgent care centers, businesses and many more. https://testing.covid19.ca.gov/covid-19-testing-task-force-laboratory-list/

The American Culture and International Innovation Cooperation Center is committed to the development of international cultural and business exchanges and promotes the development of international education.

White Plains, New York, Us

The Westchester Biotech Project Initiatives is a nonprofit association for researchers, engineers, and data scientists. Throughout the year we bring our community together through symposia, webinars, roundtables, committees, and boards. Building upon the history developed through the Westchester Biotech Project , our goal is to enhance the research and development process, with a focus upon supporting scientists as collaborators throughout their careers. http://biopharmaresearchinitiatives.org/

Siena, Tuscany, It

Exosomics Siena SpA is a leading innovative Company performing applied research and R&D activities in the field of exosome associated biomarkers, with a specific focus on the development and validation of proprietary immunometric multiplex assays for non-invasive cancer diagnostics and monitoring and point of care devices for cancer screening. We also develop arrays for companion diagnostics in collaboration for pharma companies.http://www.exosomics.eu/sab.jsp

Tallinn, Harju, Ee

HansaBioMed OU is an innovative company performing research and development in the field of Exosome Sciences. Its mission is to consolidate and maintain the worldwide leadership in production and commercialization of kits, reagents, equipment and services dedicated to exosome research for the Life Science market. HansaBioMed develops, produces and commercializes a wide range of products dedicated to the expanding market of exosome research, which are essential tools for all scientists engaged in this rapidly growing field of science. The best known of HansaBioMed owned brands is the ExoTESTTM platform, a proprietary immune-based solution to capture, quantify and characterize exosomes from biological fluids.http://www.hansabiomed.eu/index.php/component/content/article?id=3:partnering

Tinton Falls, New Jersey, Us

The BioPharma Research Council (BRC) is an independent, nonprofit organization founded in 2009 to support the broad community of scientists and business professionals in the biopharmaceutical space. By addressing scientists who are making and developing discoveries throughout the biotech/pharmaceutical pipeline, we provide an environment for interaction that can lead to better communication, enhanced collaboration, and faster, more effective medical progress.http://www.biopharmaresearchcouncil.org/scientific-advisory-board/

Beverly, Ma, Us

Genomic Expression has developed a clinically applicable, platform-agnostic sample preparation method for Next Generation Sequencing: an intelligent baitfree target filtering technology, applicable for highly complex and quantitative analysis such as RNA. The product is a kit with buffers and enzymes together with a bioinformatics tool that can be used with existing installed instruments without any modification to the instruments. In addition, they have access to the Danish health care system, which includes the largest biobank in the world, linked to electronic medical records that were established a decade ago, provide a superior hypothesis-free platform that transforms biomarker discovery from a fishing expedition into a math exercise capable of delivering proof of concept of RNA diagnostic in 1 month for $1M. This represent a paradigm shift that will save at least $20 million between 2 to 5 years of development time in the development of Next Generation Diagnostics.

The Helix Bioscience Institute was designed as the next generation not-for-profit innovation accelerator optimally leveraging the virtual with the brick and mortar. The institute will serve to enable researchers to conduct transformative directed discovery and translational research employing a vast array of tools and resources. The desired outcome is to drive innovation that directly bridges discovery to pre-clinical.http://www.helixbioscience.org/about-us/

Doha, Qa

http://www.qnrf.org/en-us/

http://hms-cssa.org/wp/?p=579

Thousand Oaks, Ca, Us

Effective May 13th 2016, SAGE is delighted to have acquired Nanobiomedicine from InTech. Nanobiomedicine is an international, peer-reviewed, open access scientific journal that publishes research in nanotechnology as it interfaces with fundamental studies in biology, as well as its application to the fields of medicine. Nanobiomedicine covers all key aspects of this research field, including, but not limited to, bioengineering, biophysics, physical and biological chemistry, and physiology, as well as nanotechnological applications in diagnostics, therapeutic application, preventive medicine, drug delivery, and monitoring of human disease. Additionally, theoretical and modeling studies covering the nanobiomedicine fields will be considered.https://uk.sagepub.com/en-gb/asi/nanobiomedicine/journal202570

Thousand Oaks, Ca, Us

I am happy to announce, the Journal of Circulating Biomarkers is now indexed in PubMed Central and Directory of Open Access Journals!Effective May 13th 2016, SAGE is delighted to have acquired Journal of Circulating Biomarkers from InTech.Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal.Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.https://uk.sagepub.com/en-gb/eur/journal-of-circulating-biomarkers/journal202569

Engaged in technology development, technology transfer, technical consulting, technical services in the field of genetic technology, biotechnology; data processing; software development; online business consulting; conference and exhibition services; own equipment leasing (not allowed to engage in financial leasing); Sales of dangerous chemicals, monitoring chemicals, civilian explosives, and precursor chemicals; engaged in the import of goods and technology. (Projects subject to approval according to law may be operated after approval by relevant departments)

CloudHealth Genomics, Ltd. is a comprehensive genomics-based precision medicine solutions provider focused on bringing the best practices in diagnostics through innovation and high-throughput genomics to the global healthcare ecosystem. CloudHealth Genomics is part of a larger CloudHealth ecosystem comprising of CloudHealth Life Center, CloudHealth High-End Clinic Center, CloudHealth Big Data Center, CloudHealth Genomics Research Institute, Academician Experts Workstation. CloudHealth Club of Medical Doctors was founded in 2014 and headquartered in Shanghai, China with international branches in US and Europe. CloudHealth Genomics prides itself with a high-throughput genomics sequencing platform and a certified clinical genetic test lab to generate genomic data, to understand, diagnose and provide solutions to treat disease with an emphasis of using “big data” to develop preventive medicine metrics and guidance to develop precision medicines for a healthier society. The goal of CloudHealth Genomics is reducing disease risks and an improved quality of life first in China, and then globally. www.chgenomics.com

Hayward, Ca, Us

Predicine Holdings Ltd is an international precision medicine organization that is committed to developing innovative diagnostics, therapeutics and big data in cancer and other serious diseases. Predicine is formed by a group of industry veterans with leadership experience and domain expertise in precision oncology, liquid biopsy, cancer diagnostics, next-generation sequencing, biomarker development, drug discovery, clinical trial, bioinformatics and cloud computing. Following the principle of science-driven and patient-first spirit, Predicine develops innovative non-invasive precision diagnostic products in cancer and other serious diseases, provides an integrated "one-stop-shop" biomarker service platform and conducts big data analyses to enable precision medicine in personalized cancer care and global drug development. The company operates in Hayward, California USA and Shanghai, China.Our vision is to connect patients and medicine. Our mission is to empower the global healthcare ecosystem through innovation and big data www.predicine.com

London, Greater London, United Kingdom, Gb

Nanobiomedicine is a unique open-access scientific journal will be available at no charge to both readers and authors that aims to publish up-to-date expert reviews, scientific manuscripts, technology reports, perspectives, opinions and editorials in the rapid emerging field of nanotechnology and biomedical research. This feature will enable the clinical and scientific community to publish their latest ground-breaking research, up-to-date reviews, perspectives and opinions quickly and at the same token, readers around the globe will be able access them online as soon as they are published. I am primarily responsible for providing editorial management of the division’s publications. I am also responsible to manage the development of new products (paper, electronic & web), partnerships and sponsorships. Manage the editorial staff and see that financial and circulation goals are met each month.http://www.intechopen.com/journals/nanobiomedicine

London, Greater London, United Kingdom, Gb

The Journal of Circulating Biomarkers mission is to engage at the international level in the translational art of the study of exosomes and microvesicles, and the interface between exosomes and microvesicles, circulating tumor cells, cell-free circulating DNA and circulating protein markers in precision medicine and drug development. I am primarily responsible for providing editorial management of the division’s publications. I am also responsible to manage the development of new products (paper, electronic & web), partnerships and sponsorships. Manage the editorial staff and see that financial and circulation goals are met each month.http://www.intechopen.com/journals/journal-of-circulating-biomarkers

London, Greater London, United Kingdom, Gb

The mission of Exosomes and Microvesicles is to publish papers that make a novel contribution to our understanding of exosomes, microvesicles, and other secreted vesicles. Several categories of papers will be published, including research articles, short reports, technical notes, reviews, letters, perspectives, and meeting summaries. The scope of the journal will match the scope of the field. I am primarily responsible for providing editorial management of the division’s publications. I am also responsible to manage the development of new products (paper, electronic & web), partnerships and sponsorships. Manage the editorial staff and see that financial and circulation goals are met each month.http://www.intechopen.com/journals/exosomesandmicrovesicles

Cambridge, Maryland, Us

IES Diagnostics, Inc. is a molecular diagnostics company with a proprietary, patent protected assay, developed at the U.S. Food and Drug Administration and licensed exclusively to IES Dx by the National Institutes of Health. This new assay is the first and only test capable of detecting and quantifying the presence and levels of ALL of the unique Interferon alpha sub-types associated with a particular disease. The unique combination of interferons produced and released by human cells when the body is exposed to an infection or disease is referred to as the “Interferon Expression Signature”.http://www.iesdiagnostics.com/management.html

My lab was funded by a Department of Defense (Naval Research Labs) grant that focused on point of care diagnostics, using magnetic levitation and microfluidics to develop devices that can be used to streamline clinical applications from sample preparation of body fluids to diagnostic/screening devices.

Boston, Ma, Us

One program within the Harvard Clinical and Translational Science Center. LITT was created at HSDM to provide the Harvard research community with early access to enabling leading edge translational technologies, which was an integral part of the Harvard Catalyst Clinical and Translational Science Center at Harvard Medical School. It is essentially a start-up within an academic center. The HC-LITT’s model is a collaborative one that interfaces between academics and industry, and it’s goal is to build communities including public private partnerships around a myriad of technologies in one place and put them to use in the hands of inventors and thought leaders to accelerate the translation of laboratory research in therapeutics and diagnostics into the clinic.

Cambridge, Massachusetts, Us

Craniofacial abnormalities are some of the most common structural birth defects that are often associated with developmental disabilities, abnormalities to brain maturation, hearing loss, functional problems related to breathing, eating, and speech. My research focused on roles of microRNAs in craniofacial development in general and in skull development in particular.

Post-Doctorate, Organismic And Evolutionary Biology - Abzhanov Lab

Doctor Of Medical Sciences (Dmsc), Oral And Computational Biology

Certificate, Oral Medicine

Certificate, Dental Informatics

Harvard/Mit Division Of Health Science Technology Sm, Biomedical Informatics

Certificate, Pediatric Dentistry/Pedodontics

Certificate, Pediatric Dentistry/Pedodontics

Certificate, General Practice Residency I & Ii

Dds, Dentistry

Master Of Public Health - Mph, Health Policy Analysis